No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
EXPO240621C65000
- 16.00
- 0.000.00%
15min DelayClose Mar 25 10:36 ET
0.00High0.00Low
0.00Open16.00Pre Close0 Volume0 Open Interest65.00Strike Price0.00Turnover328.31%IV-14.51%PremiumJun 21, 2024Expiry Date29.75Intrinsic Value100Multiplier1DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9757Delta0.0030Gamma3.16Leverage Ratio-0.1962Theta0.0024Rho3.09Eff Leverage0.0033Vega
Intraday
- 5D
- Daily
News
Exponent(EXPO.US) Director Sells US$668.52K in Common Stock
$Exponent(EXPO.US)$ Director JOHNSTON PAUL R sold 7,000 shares of common stock on Jun 17, 2024 at an average price of $95.5034 for a total value of $668.52K.Source: Announcement What is statement of c
Europastry Controlling Shareholder Exponent Plans to Sell Shares in IPO
Europastry Controlling Shareholder Exponent Plans to Sell Shares in IPO
A Look At The Fair Value Of Exponent, Inc. (NASDAQ:EXPO)
Estimating The Fair Value Of Exponent, Inc. (NASDAQ:EXPO)
Key Insights Exponent's estimated fair value is US$81.64 based on 2 Stage Free Cash Flow to Equity With US$95.15 share price, Exponent appears to be trading close to its estimated fair value Anal
Exponent(EXPO.US) Director Sells US$670.84K in Common Stock
$Exponent(EXPO.US)$ Director JOHNSTON PAUL R sold 7,000 shares of common stock on Jun 12, 2024 at an average price of $95.8344 for a total value of $670.84K.Source: Announcement What is statement of c
Exponent Insider Sold Shares Worth $670,841, According to a Recent SEC Filing
Paul R Johnston, Director, on June 06, 2024, sold 7,000 shares in Exponent (EXPO) for $670,841. Following the Form 4 filing with the SEC, Johnston has control over a total of 80,742 shares of the comp
Comments
Analysts show less optimism post recent results, cutting revenue forecasts and significantly lowering earnings per share estimates. The projected 1.8% annual growth rate till 2024 is far below the historical 7.0% p.a. growth over the past five years.
Exponent, Inc. (NASDAQ:EXPO) Just Reported And Analysts Have Been Cutting Their Estimates 1
The increase in dividend and stock repurchase authorization reflects the company's confidence in its long-term business trajectory and its commitment to delivering long-term value for shareholders.
Despite a recent share price drop, Exponent, Inc. may still hold potential for long-term investors with its consistent 13% annual return over five years. The market appears pessimistic despite the company's impressive EPS growth.
Despite Exponent's strong past earnings, its P/E is viewed as overvalued due to weaker future growth forecasts. The current elevated P/E and the predicted earnings slowdown could soon impact the stock price.
Exponent's impressive returns on its growing capital and its stable, high ROCE hint at strong future performance. Despite pricier stocks, the company's sound fundamentals warrant further research.
Read more